Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells -: A histochemical, electron-microscopic and chemical study

被引:31
作者
Chen, D [1 ]
Zhao, CM [1 ]
Norlén, P [1 ]
Björkqvist, M [1 ]
Ding, XQ [1 ]
Kitano, M [1 ]
Håkanson, R [1 ]
机构
[1] Univ Lund, Inst Physiol Sci, Dept Pharmacol, Lund, Sweden
关键词
ECL cell; cholecystokinin-2 (CCK2); receptor antagonists; gastrin; histamine; ultrastructure; rat (Sprague Dawley);
D O I
10.1007/s004419900136
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ECL cells in the oxyntic mucosa of rat stomach produce histamine and chromogranin A-derived peptides such as pancreastatin. The cells respond to gastrin via cholecystokinin-2 (CCK2) receptors. A CCK2 receptor blockade was induced by treatment (for up to 8 weeks) with two receptor antagonists, YM022 and YF476. Changes in ECL-cell morphology were examined by immunocytochemistry and electron microscopy, while changes in ECL cell-related biochemical parameters were monitored by measuring serum pancreastatin and oxyntic mucosal pancreastatin, and histamine concentrations, and histidine decarboxylase (HDC) activity. The CCK2 receptor blockade reduced the ECL-cell density only marginally, if at all, but transformed the ECL cells from slender, elongated cells with prominent projections to small, spherical cells without projections. The Golgi complex and the rough endoplasmic reticulum were diminished. Secretory vesicles were greatly reduced in Volume density in the trans Golgi area. Circulating pancreastatin concentration and oxyntic mucosal HDC activity were lowered within a few hours. Oxyntic mucosal histamine and pancreastatin concentrations were reduced only gradually. The CCK2 receptor blockade was found to prevent the effects of omeprazole-evoked hypergastrinaemia on the ECL-cell activity and density. In conclusion, gastrin, acting on CCK2 receptors, is needed to maintain the shape, size and activity of the ECL cells, but not for maintaining the ECL-cell population.
引用
收藏
页码:81 / 95
页数:15
相关论文
共 48 条
[1]   Immunohistochemical markers for enterochromaffin-like (ECL) cells of the rat stomach [J].
Andersson, J ;
Mei, Q ;
Sundler, F .
BIOMEDICAL RESEARCH-TOKYO, 1998, 19 (04) :227-236
[2]   HYPERPLASIA OF HISTAMINE-DEPLETED ENTEROCHROMAFFIN-LIKE CELLS IN RAT STOMACH USING OMEPRAZOLE AND ALPHA-FLUOROMETHYLHISTIDINE [J].
ANDERSSON, K ;
HAKANSON, R ;
MATTSSON, H ;
RYBERG, B ;
SUNDLER, F .
GASTROENTEROLOGY, 1992, 103 (03) :897-904
[3]   Gastric acid secretion after depletion of enterochromaffin-like cell histamine - A study with alpha-fluoromethylhistidine in rats [J].
Andersson, K ;
Cabero, JL ;
Mattsson, H ;
Hakanson, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (01) :24-30
[4]   Effect of alpha-fluoromethylhistidine-evoked histamine depletion on ultrastructure of endocrine cells in acid-producing mucosa of stomach in mouse, rat and hamster [J].
Andersson, K ;
Zhao, CM ;
Chen, D ;
Sundler, F ;
Hakanson, R .
CELL AND TISSUE RESEARCH, 1996, 286 (03) :375-384
[5]  
BOTTCHER G, 1989, CELL TISSUE RES, V256, P247
[6]  
CARLSSON E, 1990, DIGESTION S1, V47, P24
[7]   Time course of hypertrophic and ultrastructural responses of rat stomach enterochromaffin-like cells to sustained hypergastrinemia [J].
Chen, D ;
Zhao, CM ;
Nylander, AG ;
Hakanson, R .
CELL AND TISSUE RESEARCH, 1996, 284 (01) :55-63
[8]   Ultrastructure of enterochromaffin-like cells in rat stomach: Effects of alpha-fluoromethylhistidine-evoked histamine depletion and hypergastrinemia [J].
Chen, D ;
Zhao, CM ;
Andersson, K ;
Sundler, F ;
Hakanson, R .
CELL AND TISSUE RESEARCH, 1996, 283 (03) :469-478
[9]   ACUTE RESPONSES OF RAT STOMACH ENTEROCHROMAFFIN-LIKE CELLS TO GASTRIN - SECRETORY ACTIVATION AND ADAPTATION [J].
CHEN, D ;
MONSTEIN, HJ ;
NYLANDER, AG ;
ZHAO, CM ;
SUNDLER, F ;
HAKANSON, R .
GASTROENTEROLOGY, 1994, 107 (01) :18-27
[10]   RECEPTORS FOR GASTRIN ON GASTRIC CARCINOID-TUMOR MEMBRANE OF MASTOMYS-NATALENSIS [J].
CHIBA, T ;
KINOSHITA, Y ;
MORISHITA, T ;
NAKATA, H ;
NAKAMURA, A ;
HOSODA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (02) :739-744